Neuromelanins: a link between brain aging and neurodegenerative diseases
Physiological Reviews · 09.11.2026
DOI: 10.1152/physrev.00036.2025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Physiological Reviews, online erschienen am 09.11.2026. Verfasst von Jhanvi Soni und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Parul Institute of Pharmacy, Parul University, Vadodara 391760, Gujarat, India. Gefördert von: Ministero dell'Università e della Ricerca, Pezzoli Foundation for Parkinson's Disease, Freedom Together Foundation.
Abstract (Originalsprache)
Neuromelanins (NMs) accumulate in large amounts in catecholaminergic neurons of the substantia nigra (SN) and locus coeruleus (LC), which selectively degenerate in Parkinson’s disease (PD) and Alzheimer’s disease (AD). Lower amounts of NMs are also present in other human brain regions. NMs are contained in specialized autolysosomes with lipid bodies, proteins, and metals. Their structure, synthesis, functions, and cellular localization differ from those of melanins in non-nervous tissues. Purified NMs have a complex structure, are composed of melanic moieties, lipids, proteins, and inorganic components, and are insoluble. NMs can exert either a protective or toxic role depending on cellular context. NMs synthesis is driven by cytosolic catecholamines and is a protective process, as it removes excess cytosolic catechols that would otherwise trigger neurotoxicity. NMs can bind reactive/toxic metals, forming stable and non-toxic complexes, thereby playing a neuroprotective role. However, NMs released from degenerating neurons in PD and AD activate microglia, which release reactive species and proinflammatory factors, thereby exacerbating neuroinflammation and neurodegeneration. The major histocompatibility complex class I is present within NM-containing organelles of SN and LC neurons and can bind antigens, presenting them on the neuronal membrane. Subsequently, CD8 + T-cells may target catecholaminergic NM-containing neurons, contributing to neurodegeneration. The loss of NM-containing neurons in PD and AD causes a decrease of NMs concentration within the SN and LC, which can be visualized using magnetic resonance imaging (MRI). NM-sensitive MRI of the SN and LC is increasingly being used for the diagnosis and treatment monitoring of neurodegenerative and psychiatric disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Parul Institute of Pharmacy, Parul University, Vadodara 391760, Gujarat, India.
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), Gandhinagar 382355, Gujarat, India.
- Department of Chemistry, University of Pavia, 27100 Pavia, Italy.
- Pezzoli Foundation for Parkinson's Disease, 20125 Milan, Italy.
- Renaissance School of Medicine at Stony Brook University, Stony Brook, NY 11794, USA.
- Departments of Psychiatry, Neurology, and Pharmacology, Columbia University Medical Center, New York, NY 10032, USA.
ORCID-Profile: Luigi Zecca
Förderung
- Ministero dell'Università e della Ricerca
- Pezzoli Foundation for Parkinson's Disease
- Freedom Together Foundation
- EC | NextGenerationEU
Zitieren
APA
Soni, J., Capucciati, A., Uttarkar, M., Monzani, E., Pezzoli, G., Cassidy, C. M., Sulzer, D., Khairnar, A., Zecca, L., & Zucca, F. A. (2026). Neuromelanins: a link between brain aging and neurodegenerative diseases. Physiological Reviews. https://doi.org/10.1152/physrev.00036.2025
Vancouver
Soni J, Capucciati A, Uttarkar M, Monzani E, Pezzoli G, Cassidy CM, et al. Neuromelanins: a link between brain aging and neurodegenerative diseases. Physiological Reviews. 2026. doi:10.1152/physrev.00036.2025
BibTeX
@article{Soni2026,
author = {Soni, Jhanvi and Capucciati, Andrea and Uttarkar, Manasi and Monzani, Enrico and Pezzoli, Gianni and Cassidy, Clifford M and Sulzer, David and Khairnar, Amit and Zecca, Luigi and Zucca, Fabio A},
title = {Neuromelanins: a link between brain aging and neurodegenerative diseases},
journal = {Physiological Reviews},
year = {2026},
doi = {10.1152/physrev.00036.2025}
}
EUVIMED